1 year return (CAGR)
-59.26%
Avicanna Inc Exchange (TO, CAD)
AVCN.TO
0.10
+0.01 (+10.00%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
-36.02%
5 year return (CAGR)
-33.41%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
14.78M
Price/Sales
0.58
Ent value
24.70M
Price/Book
1.05
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-51.42%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.12 |
| Daily high | 0.12 |
| Daily low | 0.11 |
| Daily Volume | 23K |
| All-time high | 6.90 |
| 1y analyst estimate | 0.70 |
| Beta | 0.35 |
| EPS (TTM) | -0.03 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 30 Mar 2026 |
Downside potential
Loading...
Downside potential data
| AVCN.TO | S&P500 | |
| Current price drop from All-time high | -98.48% | -3.39% |
| Highest price drop | -98.55% | -56.47% |
| Date of highest drop | 2 Nov 2026 | 9 Mar 2009 |
| Avg drop from high | -89.00% | -10.64% |
| Avg time to new high | 916 days | 12 days |
| Max time to new high | 1830 days | 1805 days |
News
Results to be filed before markets open; management webcast and Q&A at 8:30 a.m. ETTORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQB: AVCNF) (FS...
November 2, 2026
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LA...
October 29, 2026
TORONTO, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commer...
October 16, 2026
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorC...
September 15, 2026
Integrating MyMedi.ca healthcare provider-guided medical cannabis care into hospitals, specialty clinics, insurers and multidisciplinary healthcare networks in CanadaTORONTO, Sept. 09, 2026 (GLOBE NEW...
September 9, 2026
Gross margin improves to 57%, supported by 48% quarterly growth in proprietary product salesQUIX™ rapid-onset portfolio prepared for Q3 launch with more than 35 commercial listings secured TORONTO, Au...
August 14, 2026
Initial Medical Cannabis SKUs, Including Rapid-Onset Capsules and Soft Chews, Planned for Q3 2026 Improving Patient Access with Accurately Dosed, Rapid-Onset and Non-Combustible Formats TORONTO, July ...
July 16, 2026
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commer...
June 30, 2026
FORT LAUDERDALE, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) today announced the completion of a CDN$300,000 strategic investment in Avicanna Inc. (TSX: A...
June 15, 2026
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LA...
June 12, 2026